Mesenchymal Stem Cells (MSCs) and Pancreatic Cancer

Mesenchymal stem cells (MSCs) are a type of adult stem cell that can be found throughout the body. These cells can differentiate into a variety of cell types, including bone, cartilage, and fat cells. In addition, MSCs can also help to regulate the immune system. While MSCs hold great promise for the treatment of a variety of diseases, there is also some concern that these cells may contribute to the development of cancer. One of the ways in which MSCs could potentially promote cancer is by inducing tumor cell growth and/or by inhibiting tumor cell death. In a recent study, researchers have found that MSCs can promote the growth of pancreatic cancer cells. The study was conducted using a mouse model of pancreatic cancer. The mice were injected with MSCs, and the researchers found that the MSCs promoted the growth of pancreatic cancer cells. In addition, the MSCs also inhibited the death of pancreatic cancer cells. This is a potentially dangerous combination, as it could lead to the development of pancreatic cancer that is resistant to treatment. While this study was conducted using a mouse model, it is possible that MSCs could have a similar effect in humans. If this is the case, it would have major implications for the treatment of pancreatic cancer. At this point, more research is needed to understand the role of MSCs in the development of cancer. However, this study provides preliminary evidence that MSCs could contribute to the growth and spread of pancreatic cancer.

 "Pancreatic cancer stem cell and mesenchymal stem cell - NCBI." https://www.ncbi.nlm.nih.gov/books/NBK98934/. Accessed 24 Oct. 2022.

 "Stromal mesenchymal stem cells facilitate pancreatic cancer ... - NCBI." 30 Jul. 2018, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096376/. Accessed 24 Oct. 2022.

 "Human amniotic fluid mesenchymal stem cells attenuate pancreatic ...." 3 Jun. 2022, https://stemcellres.biomedcentral.com/articles/10.1186/s13287-022-02910-3. Accessed 24 Oct. 2022.

The information below is the recommended stem cell therapy protocol for this condition 

Route of AdministrationDoseTime (Days)Total Cells
IV50,000,0004200,000,000
Myers cocktail/NAD50,000,0001N/A
Total200,000,000